Search Result "Agent-directed simulation"
Simulation, Intelligence and Agents: Exploring the Synergy
Ebook: Current and Future Developments in Artificial Intelligence
Volume: 1 Year: 2017
Author(s): Nasser Ghasem-Aghaee,Tuncer Ãren,Levent Yilmaz
Doi: 10.2174/9781681085029117010005
Computer Simulation of Antimicrobial Peptides
Journal: Current Medicinal Chemistry
Volume: 14 Issue: 2 Year: 2007 Page: 2789-2798
Author(s): Edit Matyus, Christian Kandt, D. Peter Tieleman
Antileishmaniasis Agents: Molecular Dynamics Simulations
Ebook: Chemoinformatics: Directions Toward Combating Neglected Diseases
Volume: 1 Year: 2012
Author(s): Tanos Celmar Costa França,Alan Wilter Sousa da Silva
Doi: 10.2174/978160805183011201010129
Recent Progress in Molecular Dynamics Simulations of Dihydrofolate Reductase
Journal: Current Enzyme Inhibition
Volume: 8 Issue: 2 Year: 2012 Page: 140-149
Author(s): John E. Kerrigan,Emine Ercikan Abali,Joseph R. Bertino
Engineering Simulations for Cancer Systems Biology
Journal: Current Drug Targets
Volume: 13 Issue: 12 Year: 2012 Page: 1560-1574
Author(s): James Bown,Paul S. Andrews,Yusuf Deeni,Alexey Goltsov,Michael Idowu,Fiona A.C. Polack,Adam T. Sampson,Mark Shovman,Susan Stepney
Introduction to Computer-Based Simulations and Methodologies in Pharmaceutical Research
Ebook: Software and Programming Tools in Pharmaceutical Research
Volume: 1 Year: 2024
Author(s):
Doi: 10.2174/9789815223019124010003
Computational Simulations of the Immune System for Personalized Medicine: State of the Art and Challenges
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 6 Issue: 4 Year: 2008 Page: 260-271
Author(s): Francesco Pappalardo, Ping Zhang, Mark Halling-Brown, Kaye Basford, Antonio Scalia, Adrian Shepherd, David Moss, Santo Motta, Vladimir Brusic
Molecular Dynamics Simulations of Protein Targets Identified in Mycobacterium tuberculosis
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 9 Year: 2011 Page: 1353-1366
Author(s): W. F. de Azevedo
Resistant Hypertension in the Elderly-Second Line Treatments: Aldosterone Antagonists, Central Alpha-Agonist Agents, Alpha-Adrenergic Receptor Blockers, Direct Vasodilators, and Exogenous Nitric Oxide Donors
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 12 Issue: 3 Year: 2014 Page: 170-173
Author(s): Carlos G. Musso,Jose Alfie